Trial · NCT03504410
Adverse events934
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 934
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal abscess | Infections and infestations | CPI-613 + HD Cytarabine and Mitoxantrone | 1 | 96 | |
| other | Abdominal abscess | Infections and infestations | Control (HAM) and Control Sub-groups (MEC and FLAG) | 0 | 97 | |
| other | Abdominal distension | Gastrointestinal disorders | CPI-613 + HD Cytarabine and Mitoxantrone | 3 | 96 | |
| other | Abdominal distension | Gastrointestinal disorders | Control (HAM) and Control Sub-groups (MEC and FLAG) | 3 | 97 | |
| other | Abdominal pain | Gastrointestinal disorders | CPI-613 + HD Cytarabine and Mitoxantrone | 5 | 96 | |
| other | Abdominal pain | Gastrointestinal disorders | Control (HAM) and Control Sub-groups (MEC and FLAG) | 7 | 97 | |
| other | Abdominal pain upper | Gastrointestinal disorders | CPI-613 + HD Cytarabine and Mitoxantrone | 3 | 96 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Control (HAM) and Control Sub-groups (MEC and FLAG) | 1 | 97 | |
| other | Abnormal loss of weight | Metabolism and nutrition disorders | CPI-613 + HD Cytarabine and Mitoxantrone | 1 | 96 | |
| other | Abnormal loss of weight | Metabolism and nutrition disorders | Control (HAM) and Control Sub-groups (MEC and FLAG) | 0 | 97 | |
| other | Abscess limb | Infections and infestations | CPI-613 + HD Cytarabine and Mitoxantrone | 1 | 96 | |
| other | Abscess limb | Infections and infestations | Control (HAM) and Control Sub-groups (MEC and FLAG) | 0 | 97 | |
| other | Achromobacter infection | Infections and infestations | CPI-613 + HD Cytarabine and Mitoxantrone | 0 | 96 | |
| other | Achromobacter infection | Infections and infestations | Control (HAM) and Control Sub-groups (MEC and FLAG) | 1 | 97 | |
| other | Acidosis | Metabolism and nutrition disorders | CPI-613 + HD Cytarabine and Mitoxantrone | 0 | 96 | |
| other | Acidosis | Metabolism and nutrition disorders | Control (HAM) and Control Sub-groups (MEC and FLAG) | 1 | 97 | |
| other | Activated partial thromboplastin time prolonged | Investigations | CPI-613 + HD Cytarabine and Mitoxantrone | 1 | 96 | |
| other | Activated partial thromboplastin time prolonged | Investigations | Control (HAM) and Control Sub-groups (MEC and FLAG) | 1 | 97 | |
| other | Acute kidney injury | Renal and urinary disorders | CPI-613 + HD Cytarabine and Mitoxantrone | 8 | 96 | |
| other | Acute kidney injury | Renal and urinary disorders | Control (HAM) and Control Sub-groups (MEC and FLAG) | 0 | 97 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03504410/events